232 related articles for article (PubMed ID: 37744271)
1. Deciphering key genes involved in cisplatin resistance in kidney renal clear cell carcinoma through a combined
Malik M; Maqbool M; Nisar T; Akhter T; Ujan JA; Algarni AS; Joufi FAA; Alanazi SSK; Almotared MH; Bekhit MMS; Jamil M
Oncol Res; 2023; 31(6):899-916. PubMed ID: 37744271
[TBL] [Abstract][Full Text] [Related]
2. The discovery of promising candidate biomarkers in kidney renal clear cell carcinoma: evidence from the in-depth analysis of high-throughput data.
Li X; Li M; Zhao T; Zhang J
Am J Cancer Res; 2023; 13(9):4288-4304. PubMed ID: 37818073
[TBL] [Abstract][Full Text] [Related]
3. Identifying and validating MMP family members (MMP2, MMP9, MMP12, and MMP16) as therapeutic targets and biomarkers in kidney renal clear cell carcinoma (KIRC).
Li K; Li D; Hafez B; Bekhit MMS; Jardan YAB; Alanazi FK; Taha EI; Auda SH; Ramzan F; Jamil M
Oncol Res; 2024; 32(4):737-752. PubMed ID: 38560573
[TBL] [Abstract][Full Text] [Related]
4. Characterization and verification of MMP family members as potential biomarkers in kidney clear cell renal carcinoma.
Zhao T; Li X; Li M; Jamil M; Zhang J
Am J Cancer Res; 2023; 13(9):3941-3962. PubMed ID: 37818055
[TBL] [Abstract][Full Text] [Related]
5. Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma.
Qiu J; Wang Z; Xu Y; Zhao L; Zhang P; Gao H; Wang Q; Xia Q
BMC Urol; 2023 Mar; 23(1):45. PubMed ID: 36978048
[TBL] [Abstract][Full Text] [Related]
6. Screening Novel Drug Candidates for Kidney Renal Clear Cell Carcinoma Treatment: A Study on Differentially Expressed Genes through the Connectivity Map Database.
Gao B; Wang L; Zhang N; Han M; Zhang Y; Liu H; Sun D; Liu Y
Kidney Blood Press Res; 2021; 46(6):702-713. PubMed ID: 34818247
[TBL] [Abstract][Full Text] [Related]
7. Identification of useful biomolecular markers in kidney renal clear cell carcinoma: an in silico and in vitro analysis-based study.
Sheikh K; Memon KN; Usman H; Abdel-Maksoud MA; Ullah S; Almanaa TN; Chaudhary A; Jamil M; Gill OBQ; Yar MA; Hussein AM; Zakri AM
Am J Transl Res; 2023; 15(9):5574-5593. PubMed ID: 37854221
[TBL] [Abstract][Full Text] [Related]
8.
Situ Y; Zhang J; Liao W; Liang Q; Lu L; Xu Q; Chen J; Lu X; Cui Y; Shao Z; Deng L
Front Biosci (Landmark Ed); 2023 Sep; 28(9):196. PubMed ID: 37796681
[TBL] [Abstract][Full Text] [Related]
9. FMR1 is identified as an immune-related novel prognostic biomarker for renal clear cell carcinoma: A bioinformatics analysis of TAZ/YAP.
Wu S; He H; Huang J; Jiang S; Deng X; Huang J; Chen Y; Jiang Y
Math Biosci Eng; 2022 Jun; 19(9):9295-9320. PubMed ID: 35942760
[TBL] [Abstract][Full Text] [Related]
10. Identification of hub genes involved in cisplatin resistance in head and neck cancer.
Chaudhary RK; Khanal P; Mateti UV; Shastry CS; Shetty J
J Genet Eng Biotechnol; 2023 Jan; 21(1):9. PubMed ID: 36715825
[TBL] [Abstract][Full Text] [Related]
11. CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
Zou X; Mo Z
Biomed Res Int; 2021; 2021():3771866. PubMed ID: 34258261
[TBL] [Abstract][Full Text] [Related]
12. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
13. The promising novel biomarkers and candidate small molecule drugs in kidney renal clear cell carcinoma: Evidence from bioinformatics analysis of high-throughput data.
Zhang B; Wu Q; Wang Z; Xu R; Hu X; Sun Y; Wang Q; Ju F; Ren S; Zhang C; Qin L; Ma Q; Zhou YL
Mol Genet Genomic Med; 2019 May; 7(5):e607. PubMed ID: 30793530
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma.
Wu Y; Xu Z; Chen X; Fu G; Tian J; Shi Y; Sun J; Jin B
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109674
[No Abstract] [Full Text] [Related]
15. A novel prognostic signature of chemokines for survival and immune infiltration in kidney renal clear cell carcinoma.
Weng J; Huang Z; Li Q; Huang Y; Chen S
Int J Med Sci; 2023; 20(8):1046-1059. PubMed ID: 37484803
[No Abstract] [Full Text] [Related]
16. Supervised Learning and Multi-Omics Integration Reveals Clinical Significance of Inner Membrane Mitochondrial Protein (IMMT) in Prognostic Prediction, Tumor Immune Microenvironment and Precision Medicine for Kidney Renal Clear Cell Carcinoma.
Chen CC; Chu PY; Lin HY
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240154
[TBL] [Abstract][Full Text] [Related]
17. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
[TBL] [Abstract][Full Text] [Related]
18. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.
Xing Q; Ji C; Zhu B; Cong R; Wang Y
Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of shared gene signature of kidney renal clear cell carcinoma and COVID-19.
Nie J; Yang H; Liu X; Deng W; Fu B
PeerJ; 2024; 12():e16927. PubMed ID: 38464749
[TBL] [Abstract][Full Text] [Related]
20. In vitro analysis of PI3K pathway activation genes for exploring novel biomarkers and therapeutic targets in clear cell renal carcinoma.
Ali L; Raza AA; Zaheer AB; Alhomrani M; Alamri AS; Alghamdi SA; Almalki AA; Alghamdi AA; Khawaja I; Alhadrami M; Ramzan F; Jamil M; Ali M; Jabeen N
Am J Transl Res; 2023; 15(7):4851-4872. PubMed ID: 37560222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
